CNQ:RVV

Revive Therapeutics Ltd. Stock Insider Trading

Canadian Securities Exchange > Healthcare > Drug Manufacturers—Specialty & Generic

$0.0100

+0 (+0%)

At Close: Jun 28, 2024

Revive Therapeutics Ltd. Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 RVV.CN shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About Revive Therapeutics Ltd.

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clinical study for treating ... RVV.CN Profile

Golden Star

Ticker	Date	Change	Price
FFIV	Jun 26	1.75%	$169.26
VIGI	Jun 26	0.694%	$80.72
EHC	Jun 25	1.08%	$84.87
SNAP	Jun 24	6.00%	$15.67
EVBG	Jun 21	0.662%	$34.76
DDOG	Jun 21	10.31%	$117.57
SRE	Jun 20	0.768%	$75.48
PEG	Jun 20	0.163%	$73.58
DOC	Jun 20	1.14%	$19.38
EPD	Jun 18	2.40%	$28.30

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In